Tool Identifies Likely Reservoir Species for SARS-CoV-2

Researchers used sequencing data and phenotypic traits to predict which of 5,400 species were most likely to be susceptible to contracting and spreading the virus back to humans.

Written byEmma Yasinski
| 4 min read
Small group of Scimitar-horned oryx
Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

As public health experts continue to wrestle with the spread of SARS-CoV-2 among people, concerns that the virus may find other viable hosts have grown. If humans pass the virus on to other species that are susceptible to infection, those animals could act as a reservoir for the virus and eventually pass mutated versions back to humans, extending and potentially worsening the pandemic. The big question is which species are most likely to pose this risk.

To begin to answer that, researchers from the Cary Institute of Ecosystem Studies in New York have developed a machine-learning model that uses an animal’s traits to predict the structure of its angiotensin converting enzyme 2 (ACE2) receptors—the primary molecular receptor SARS-CoV-2 uses to enter cells. Based on those structures, the team identified species most likely to be susceptible to contracting and spreading SARS-CoV-2, the team reports today (November 16) in Proceedings of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • emma yasinski

    Emma is a Florida-based freelance journalist and regular contributor for The Scientist. A graduate of Boston University’s Science and Medical Journalism Master’s Degree program, Emma has been covering microbiology, molecular biology, neuroscience, health, and anything else that makes her wonder since 2016. She studied neuroscience in college, but even before causing a few mishaps and explosions in the chemistry lab, she knew she preferred a career in scientific reporting to one in scientific research.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies